ESC Congress 2023 David Conen presents the results of the COP-AF trial that demonstrated that colchicine did not reduce the incidence on perioperative AF or myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery. However, there were promising trends across multiple secondary and post-hoc outcomes.
This video was recorded during the ESC Congress 2023 in Amsterdam, The Netherlands.
David Conen,MD is internist and cardiologist. He is Scientist and Principal Investigator at the Population Health Research Institute, McMaster University in Hamilton, ON, Canada, where he holds an appointment as Associate Professor, Department of Medicine.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
- ESC Congress 2023Development of the SCORE2-ASIA CVD risk prediction algorithm
Sofian Johar, MD, PhD
Steven Hageman, MD, PhD
Ruxandra Maria Christodorescu, MD
Nadia Bonekamp, MD
Joseph Wu, MD, PhD
- ESC Congress 2023Artificial intelligence for the management of HF
Folkert Asselbergs, MD, PhD
Pascal Burger, MD